Association Between Chlamydia pneumoniae and Migraine: A Study from a Tertiary Center in India

Aims: To investigate the association between circulating Chlamydia pneumoniae (C pneumoniae) immunoglobulin G (IgG) antibody and migraine in Indian patients. Methods: A total of 300 migraine patients and 150 age-matched and sex-matched controls were recruited from the Department of Neurology at Yashoda Hospital in Hyderabad, India, during the study period between August 2011 and July 2013. All patients and controls were assessed for the presence of the C pneumoniae IgG antibody and also C-reactive protein (CRP) as well as for depression, which was assessed by the Hamilton Depression Rating Scale (HDRS). Results: Of the patients with migraine, 69% were female and the mean age ± standard deviation (SD) was 45.8 ± 4.8 years (range 18 to 62 years). The C pneumoniae IgG antibody was present in 151 of the patients (50.3%; P < .0001), CRP in 180 (60%; P < .0001), depression in 270 (90%; P < .0001), and history of sleep disturbances in 70 (23.3%; P < .0001); all measurements were significantly higher in migraine patients compared with controls. After adjustment for multiple logistic regression analyses, C pneumoniae IgG antibody positivity (odds ratio [OR] 2.6; 95% confidence interval [CI] = 1.3 to 3.7), CRP positivity (OR 6.2; 95% CI = 3.3 to 11.6), mild depression (OR 16.9; 95% CI = 6.5 to 39.4), and history of sleep disturbance (OR 2.1; 95% CI = 1.1 to 3.1) were independently associated with migraine. Conclusion: This study showed that the presence of C pneumoniae IgG antibody was independently associated with migraine in Indian patients.

C pneumoniae positive; C-reactive protein; history of sleep disturbance; Indian population; migraine

1. Headache Classification Committee of the International Headache Society (IHS). The International Classification of Headache Disorders, 3rd edition (beta version). Cephalalgia 2013;33:629–808.

2. Weinberger J. Stroke and migraine. Curr Cardiol Rep 2007;9:13–19.

3. Guendler VZ, Mercante JP, Ribeiro RT, Zukerman E, Peres MF. Factors associated with acute medication overuse in chronic migraine patients. Einstein (Sao Paulo) 2012;10:312–317.

4. Amin FM, Asghar MS, Hougaard A, et al. Magnetic resonance angiography of intracranial and extracranial arteries in patients with spontaneous migraine without aura: A cross-sectional study. Lancet Neurol 2013;12:454–461.

5. Eising E, A Datson N, van den Maagdenberg AM, Ferrari MD. Epigenetic mechanisms in migraine: A promising avenue?BMC Med 2013;11:26.

6. Lu Q, Xu J, Liu H. Association between Chlamydia pneumoniae IgG antibodies and migraine. J Headache Pain 2009;10:121–124.

7. Bandaru VC, Laxmi V, Neeraja M, et al. Chlamydia pneumoniae antibodies in various subtypes of ischemic stroke in Indian patients. J Neurol Sci 2008;272:115–122.

8. Bandaru VC, Kaul S, Laxmi V, et al. Antibodies to Chlamydia pneumoniae are associated with increased intima media thickness in asymptomatic Indian individuals. J Stroke Cerebrovasc Dis 2009;18:190–194.

9. Hornung, Lisa. Infections may cause depression. http://sciencenordic.com/infections-may-cause-depression. Accessed 10 October 2014.

10. Breslau N, Schultz LR, Stewart WF, Lipton RB, Lucia VC, Welch KM. Headache and major depression: Is the association specific to migraine? Neurology 2000;54:308–313.

11. Bhurgri GR, Buksh H, Qureshi MA. Frequency of Depression in Migraine patients. GJMS 2009;7:106–108.

12. Master-Hunter T, Heiman DL. Amenorrhea: Evaluation and treatment. Am Fam Physician 2006;73:1374–1382.

13. Sarchielli P, Alberti A, Codini M, Floridi A, Gallai V. Nitric oxide metabolites, prostaglandins and trigeminal vasoactive peptides in internal jugular vein blood during spontaneous migraine attacks. Cephalalgia 2000;20:907–918.

14. Gruber HJ, Bernecker C, Lechner A, et al. Increased nitric oxide stress is associated with migraine. Cephalalgia 2010; 30:486–492.

15. Yilmaz G, Sürer H, Inan LE, Coskun O, Yücel D. Increased nitrosative and oxidative stress in platelets of migraine patients. Tohoku J Exp Med 2007;211:23–30.

16. Yilmaz N, Aydin O, Yegin A, Tiltak A, Eren E. Increased levels of total oxidant status and decreased activity of arylesterase inmigraineurs. Clin Biochem 2011;44:832–837.

17. Rezazadeh M, Hajilooi M, Rafiei A, et al. TLR4 polymorphism in Iranian patients with brucellosis. J Infect 2006;53:206–210.

18. Tunca A, Türkay C, Tekin O, Kargili A, Erbayrak M. Is Helicobacter pylori infection a risk factor for migraine? A case-control study. Acta Neurol Belg 2004;104:161–164.

19. Peroutka SJ. Neurogenic inflammation and migraine: Implications for therapeutics. Mol Interv 2005;5:304–311.

20. Reuter U, Bolay H, Jansen-Olesen I, et al. Delayed inflammation in rat meninges: Implications for migraine pathophysiology. Brain 2001;124:2490–2502.

21. Bolay H, Reuter U, Dunn AK, Huang Z, Boas DA, Moskowitz MA. Intrinsic brain activity triggers trigeminal meningeal afferents in a migraine model. Nat Med 2002;8:136–142.

22. Arbour NC, Lorenz E, Schutte BC, et al. TLR4 mutations are associated with endotoxin hyporesponsiveness in humans. Nat Genet 2000;25:187–191.

23. Theodoropoulos DS, Katzenberger DR, Jones WM, et al. Allergen-specific sublingual immunotherapy in the treatment of migraines: A prospective study. Eur Rev Med Pharmacol Sci 2011;15:1117–1121.

24. Welch KM, Brandes AW, Salerno L, Brandes JL. C-reactive protein may be increased in migraine patients who present with complex clinical features. Headache 2006;46:197–199.

25. Salehi H, Aminianfar M, Ranjbar-Naeeni A, Saidi A, Rastgoo

F. Comparison of serum CRP in migraine sufferers and normal population. ZJRMS 2014;16:13–16.

26. Bulboaca A, Ursu C, Uifalean A, Bulboaca A. Correlation between migraine severity and comorbidities in episodic migraine. Romanian J Neurol 2015;14:85–89.

27. Tietjen GE, Khubchandani J, Herial NA, Shah K. Adverse childhood experiences are associated with migraine and vascular biomarkers. Headache 2012;52:920–929.

28. Nelson KB, Richardson AK, He J, Lateef TM, Khoromi S, Merikangas KR. Headache and biomarkers predictive of vascular disease in a representative sample of US children. Arch Pediatr Adolesc Med 2010;164:358–362.

29. Kurth T, Ridker PM, Buring JE. Migraine and biomarkers of cardiovascular disease in women. Cephalalgia 2008;28:49–56.

30. Fava A, Pirritano D, Consoli D, et al. Chronic migraine in women is associated with insulin resistance: A cross-sectional study. Eur J Neurol 2014;21:267–272.

31. Goulis DG, Chappell L, Gibbs RG, et al. Association of raised titres of antibodies to Chlamydia pneumoniae with a history ofpre-eclampsia. BJOG 2005;112:299–305.

32. Kohara K, Tabara Y, Yamamoto Y, Igase M, Miki T. Chlamydia pneumoniae seropositivity is associated with increased plasma levels of soluble cellular adhesion molecules in community-dwelling subjects: The Shimanami Health Promoting Program (J-SHIPP) study. Stroke 2002;33:1474–1479.

33. Wacogne C, Lacoste JP, Guillibert E, Hugues FC, Le Jeunne

C. Stress, anxiety, depression and migraine. Cephalagia 2003; 23:451–455.

34. Siniatchkin M, Riabus M, Hasenbring M. Coping styles of headache sufferers. Cephalalgia 1999;19:165–173.

35. Tan FU, Özen NE, Kazezog˘ lu S, Kökog˘ lu F, Boratay C. Depression and anxıety in patıents with migraine and tension-type headache. Gazi Medical Journal 2005;16:74–79.

36. Hamelsky SW, Lipton RB. Psychiatric comorbidity of migraine. Headache 2006;46:1327–1333.

37. Ma Y, Chiriboga DE, Pagoto SL, et al. Association between depression and C-reactive protein. Cardiol Res Pract 2010; 2011:286509.

38. Wang X, Zhang L, Lei Y, et al. Meta-analysis of infectious agents and depression. Sci Rep 2014;4:4530.

39. Rains J. Sleep Disorders and Headache. American Headache Society. http://www.achenet.org/resources/sleep_disorders_ and_headache. Accessed dated 25 September 2015.

40. Rains JC, Poceta JS, Penzien DB. Sleep and headaches. Curr Neurol Neurosci Rep 2008;8:167–175.

41. Finan PH, Smith MT. The comorbidity of insomnia, chronic pain, and depression: Dopamine as a putative mechanism. Sleep Med Rev 2013;17:173–183.

42. Hosseinzadeh M, Khosravi A, Saki K, Ranjbar R. Evaluation of Helicobacter pylori infection in patients with common migraine headache. Arch Med Sci 2011;7:844–849.

43. Vahdat K, Dadjou H, Hadavand F, et al. The association of Chlamydia pneumoniae IgG seropositivity with an atherogenic lipid profile in a general population: The Persian Gulf Health Heart Study. Austin J Endocrinol Diabetes 2014;2:1026.

44. Bagaitkar J, Demuth DR, Scott DA. Tobacco use increases susceptibility to bacterial infection. Tob Induc Dis 2008;4:12.

45. Zhao X, Bu DX, Hayfron K, et al. A combination of secondhand cigarette smoke and Chlamydia pneumoniae accelerates atherosclerosis. Atherosclerosis 2012;222:59–66.

46. Yu S, Liu R, Yang X, et al. Body mass index and migraine: A survey of the Chinese adult population. J Headache Pain 2012;13:531–536.